Inhalation is the preferred route of drug administration in chronic respiratory diseases because it optimises delivery of the active compounds to the targeted site and minimises side effects from systemic distribution. The choice of a device should be made after careful evaluation of the patient's clinical condition (degree of airway obstruction, comorbidities), as well as their ability to coordinate the inhalation manoeuvre and to generate sufficient inspiratory flow. These patient factors must be aligned with the specific advantages and limitations of each inhaler when making this important choice. Finally, adherence to treatment is not the responsibility of the patient alone, but should be shared also by clinicians. Clinicians have access to a wide selection of pressurised metered dose inhalers (pMDIs) and dry powder inhalers (DPIs) that can be used effectively when matched to the needs of individual patients; this should be perceived as an opportunity rather than a limitation.

Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? / Scichilone, Nicola; Benfante, Alida; Bocchino, Marialuisa; Braido, Fulvio; Paggiaro, Pierluigi; Papi, Alberto; Santus, Pierachille; SANDUZZI ZAMPARELLI, Alessandro. - In: PULMONARY PHARMACOLOGY & THERAPEUTICS. - ISSN 1094-5539. - 31:(2015), pp. 63-7-67. [10.1016/j.pupt.2015.02.006]

Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?

BOCCHINO, MARIALUISA;SANDUZZI ZAMPARELLI, ALESSANDRO
2015

Abstract

Inhalation is the preferred route of drug administration in chronic respiratory diseases because it optimises delivery of the active compounds to the targeted site and minimises side effects from systemic distribution. The choice of a device should be made after careful evaluation of the patient's clinical condition (degree of airway obstruction, comorbidities), as well as their ability to coordinate the inhalation manoeuvre and to generate sufficient inspiratory flow. These patient factors must be aligned with the specific advantages and limitations of each inhaler when making this important choice. Finally, adherence to treatment is not the responsibility of the patient alone, but should be shared also by clinicians. Clinicians have access to a wide selection of pressurised metered dose inhalers (pMDIs) and dry powder inhalers (DPIs) that can be used effectively when matched to the needs of individual patients; this should be perceived as an opportunity rather than a limitation.
2015
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? / Scichilone, Nicola; Benfante, Alida; Bocchino, Marialuisa; Braido, Fulvio; Paggiaro, Pierluigi; Papi, Alberto; Santus, Pierachille; SANDUZZI ZAMPARELLI, Alessandro. - In: PULMONARY PHARMACOLOGY & THERAPEUTICS. - ISSN 1094-5539. - 31:(2015), pp. 63-7-67. [10.1016/j.pupt.2015.02.006]
File in questo prodotto:
File Dimensione Formato  
Scichilone_PPT_15.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 295.25 kB
Formato Adobe PDF
295.25 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/612031
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact